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1. Introduction 
6Aminonicotinamide (6AN) can replace the nico- 
tinamide moiety of pyridine nucleotides both in vitro 
and in vivo in the reaction ,catalysed by the enzyme 
NAD(P) glycohydrolase (E.C.3.3.3.6) or in the course 
of a de novo synthesis of NAD or NADP; the resulting 
antimetabolites (6-ANAD or 6-ANADP) may inhibit 
pyridine nucleotide linked reactions [l-5] . After in- 
jection of 6-AN into pregnant experimental nimals, 
embryotoxic effects can be demonstrated [6-81. In 
adult animals, the application of this antimetabolite 
leads to typical lesions of the central nervous ystem, 
including irreversible paralysis [4,9] . An increase in 
the concentration of 6phosphogluconate (6%) in 
rat brains in vivo following the injection of 6-AN [ 12, 
131 suggests an impairment at the 6-phosphogluconate 
dehydrogenase level. 
Earlier studies have shown an impaired function of 
the oxidative part of the pentose phosphate pathway 
(PPP) in embryos of experimental nimals treated 
with 6-AN and an inhibition of the incorporation of 
carbon atoms from glucose into the ribose moiety of 
nucleic acids via the NADP dependent steps [8] . We 
have tried to localize the block in the PPP. 
In this paper, we present he results of kinetic 
studies on the effect of 6-aminonicotinamide adenine 
dinucleotide phosphate (B-ANADP). 
2. Materials and methods 
2.1. Kinetic studies 
Hyaloplasmic fractions from various rat tissue were 
used for the kinetic studies. After homogenizing the 
tissue in 0.32 M sucrose t 1 mM Mp, pH 7.4 and 
Table 1 
Effect of 6-ANADP on some NADP-dependent enzyme reactions of various rat tissues. 
Tissue Enzyme v a max Km NADP(HZ) 
(crM) 
Ki 6-ANADP 
(PM) 
G6-PD 32 14 70 
Embryo, day 13 6-PGD 30 11 0.2 
GSSG reductase 9 6 46 
Liver G-6-PD 35 20 110 
6-PGD 73 13 0.2 
Mammary gland 6-PGD 249 13 0.1 
All numbers give the mean values of several experiments. 
a mrmoles NADP(H2) converted X min -1 X mg protein -1. 
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Table 2 
Formation of 14CO2 and incorporation into DNA and lipids from l- 14C- and 6-14C-glucose byintact rat embryos in vitro 
(Mean f S.D., n = 10). 
CO2 (dpm X pg DNA -l) DNA (dpm X fig DNA -l) Lipids (dpm X pg DNA -l) 
Cl C6 Cl C6 Cl/C6 Cl C6 C] /CA 
Control 8.80 + 2.30 <0.02 0.95 f 0.16 0.89 + 0.06 1.07 1.80 f. 0.20 1.60 +O.lO 1.11 
6-AN-treated <0.02a < 0.02 1.03 + 0.05 0.73 + 0.07a 1.41 0.92 + 0.20a 0.85 + 0.09 1.08 
ap <0.005 
15 mg kg1 6-AN were given i.p. to the mothers 4 hr before the experiment. Rat embryos (day 13) were incubated at 37’C for 3 
mm in a saline medium containing 10 nCi glucose (3.3 r.KJi/fimole). 
1 
” 
Fig. 1. Inhibition of 6-PGD from rat embroys by 6-ANADP. v = mnmoles NADP reduced X min -1 X mg protein -1. Km = 13 MM 
Ki = 0.24 PM. Assay mixture: 4 mM Mg 2+, 10 mM nicotinamide, 20 mM 6-phosphogluconate, trisodium and 100 mM tripHC1 
pH 7.5. 
centrifuging for 90 min at 100,000 g in a Spinco ul- 
tracentrifuge, the supernatant was passed through 
Sephadex G-25 columns to remove substances of low 
molecular weight. Enzymic activities were measured 
spectrophotometrically at 340 nm or 366 nm. Re- 
cording spectrophotometers from Leitz-Unicam or 
Eppendorf were used. All experiments were performed 
at 25’C. Vmax, Km and 4 values were derived both 
graphically and mathematically using a Wang 370 
computing system and the statistical estimations of 
Wilkinson [lo] from at least 4 independent sets of 
data. DNA was measured the method of Burton [ 141. 
2.2. Inhibitor 
The 6-AN analogue of NADP was prepared using 
hog brain NAD(P) glycohydrolase (E.C.3.3.3.6). The 
analogue was isolated and purified by chromatography 
[3]. The product had a purity of at least 95%. 
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2.3. Metabolism of 14C-glucose 
Pregnant rats were treated with 5-15 mg/kg 6-AN 
i.p. 4-40 hr prior to the experiment. Embryos (day 
13) were removed and incubated for 3 min at 37°C 
with 1-14C, 2-14C or 6-14C-glucose (10 #J/3 moles) 
in 1 ml of a medium containing 150 mM NaCl, 50 mM 
KCl, 3 mM Mp and 60 mM phosphate buffer pH 7.5. 
14C02 was absorbed with NaOH and incorporation of 
14C into lipids, nucleic acids and proteins was mea- 
ured, respectively, by successive extraction of the 
washed (5 times) perchloric acid (0.2 N) precipitate 
with alcohol-ether (3 : 1,3 times) and 0.3 N NaOH 
(37°C 1 hr) followed by acidification with 0.2 N 
perchloric acid (75’C, 15 min, twice). 
3. Results and discussion 
So far, no indication that 6-ANADP or 6ANAD 
can be reduced by any enzymatic reaction has been 
obtained, but earlier studies have shown the analogues 
to be competitive inhibitors of some NAD(P)-linked 
oxidoreductases [2,4]. 
3.1. Kinetic studies with GANADP 
Results obtained with enzymes from embryonic 
tissues are shown in fig. 1 and table 1. Glucose-6- 
phosphate dehydrogenase (G&PD, E.C. 1.1.1.49) is 
inhibited competively; the Ki found with the enzyme 
from mammalian embryos (70 JIM) is somewhat higher 
than that published [2] for the corresponding enzyme 
from yeast (20-30 MM). It is interesting to note that 
6-ANADP the analogue in the oxidized form, also 
inhibits the conversion catalysed by glutathione re- 
ductase (E.C. 1.6.4.2), an enzyme reaction proceeding 
in the direction NADPH, to NADP. Similarly to 
G-6-PD, this enzyme is also moderately inhibited, the 
Ki being 46 /JM. 
In contrast o enzymic studies o far, 6-phospho- 
gluconate dehydrogenase (6PGD, E.C. 1.1.1.44) from 
mammalian embryos is inhibited by concentrations 
of the analogue that are several orders of magnitude 
lower. As shown in fig. 1, the 4 for 6-ANADP in this 
reaction is 0.2 @I. Because of substrate inhibition, 
conclusive data could be obtained only in a narrow 
range of NADP concentrations but from a variety of 
plots (I/v versus l/s, s/v versus , l/v versus i and 
i&o versus ) the data available suggest competitive 
inhibition. To our knowledge, this is the strongest 
inhibition of an oxidoreductase by an analogue of 
pyridine nucleotides o far published. The malic en- 
zyme reaction [4], which also includes a decarbox- 
ylation step was previously found to be most sensi- 
tive to 6-ANADP. 
To compare the sensitivity of the embryonic en- 
zyme with those of enzymes from adult tissues, the 
4 for 6-ANADP on 6-PGD in a variety of tissues 
(table 1) was measured but no real differences were 
found. These results were confirmed recently with an 
enzyme from rat brain [ 151.. 
3.2. Studies on the metabolism of 14C-glucose 
To ellucidate further the effect of the NADP-ana- 
logue on the function of the pentose phosphate path- 
way (PPP) and its coupling to nucleic acid synthesis, 
the metabolism of glucose was studied in intact 
mammalian embryos. In embryonic tissue, riboss5- 
phosphate isan essential requirement, since nucleic 
acid synthesis proceeds at a very high rate and its 
content may increase 7 fold during 24hr period [ 1 l] . 
The results of one experiment with 1-14C and 6-14C- 
glucose in vitro, showing the effect of 6-AN treatment 
in vivo, are given in table 2. The data show clearly 
that under our experimental conditions, the reactions 
of the PPP are studied almost exclusively and that CO, 
formation via respiration does not contribute to a 
measurable extent. Furthermore, as judged from stud- 
ies with 2-14C-glucose “recycling” may be neglected. 
5 hr after the injection of 15 mg/kg 6-AN to the 
mother animal, no formation of l4cO2 from 1J4C- 
glucose could be detected in the embryo, indicating 
a complete inhibition of the oxidative part of the 
PPP. This confirms our earlier fmdings [8]. 
Although 6-AN treatment leads to a complete 
block in the oxidative part of PPP, apparently at the 
level of 6-PGD, the embryotoxic ribose effect is not 
caused by prevention of ribose formation via 6-PG. 
No significant inhibition of the overall incorporation 
of glucose-fragments into the ribose moiety of DNA 
and RNA by low doses of 6-AN at short time intervals 
was dectable in these experiments and in many ex- 
periments asigificant increase in the rate of labelling 
was seen. 
Earlier experiments performed in collaboration 
with Dr. Brand (Max-Planck-Institut fur Ernahrungs- 
forschung, Dortmund) and to be reported elsewhere 
in detail, have shown that the oxidative part of the 
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PPP plays a minor role in early mammalian embryos (The results of a detailed analysis of the inhibition 
compared with the non-oxidative part. As calculated of these two enzymes from different sources will 
from the data given here, at least 85% of the radio- be published elsewhere). The analogue may also 
activity found in the DNA was incorporated via the provide a valuable tool for studying the significance 
non-oxidative part; thus even complete block of the of the oxidative part of the PPP and the coupling of 
oxidative part of the PPP would not significantly this metabolic pathway to other reactions in vivo and 
effect ribose formation. in vitro in a variety of tissues. 
Following a complete block in the oxidative part 
of the PPP, the ratio of the incorporation of 1-14C 
to 6-14C-glucose would be expected to increase and 
approach the theoretical value of 1 S. Under suitable 
conditions this effect can be demonstrated (table 2). 
In contrast o the incorporation of glucose into the 
ribose moiety of DNA and RNA, the labelling of 
lipids significantly decreased under the same experi- 
mental conditions (table 2). Since the rate of aerobic 
lactate formation did not change, an inhibition of 
the glycolytic pathway is unlikely. An impaired pro- 
duction of reduced NADP may therefore be of greater 
importance. 
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